Immix Biopharma Inc. (IMMX)
2.02
-0.04 (-1.94%)
At close: Jan 17, 2025, 3:59 PM
2.08
2.97%
After-hours Jan 17, 2025, 04:48 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | n/a | -89.52M | n/a | n/a | n/a |
| Cost of Revenue | 5.47K | 2.13K | 2.47K | 2.32K | 1.08K |
| Gross Profit | -5.47K | -89.52M | -2.47K | -2.32K | -1.08K |
| Operating Income | -16.14M | -8.22M | -1.35M | -453.85K | -842.50K |
| Interest Income | 572.01K | 0.50 | 179.85 | 101.98 | 109.98 |
| Pretax Income | -15.57M | -8.22M | -24.38M | -1.13M | -952.26K |
| Net Income | -15.43M | -8.23M | -24.38M | -1.15M | -972.81K |
| Selling & General & Admin | 7.41M | 4.02M | 1.23M | 205.70K | 259.34K |
| Research & Development | 8.74M | 4.20M | 126.53K | 248.15K | 583.16K |
| Other Expenses | n/a | n/a | n/a | 512.00 | 224.00 |
| Operating Expenses | 16.14M | 8.22M | 1.35M | 453.85K | 842.50K |
| Interest Expense | n/a | 497.00 | 179.85K | 101.98K | 109.98K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 16.14M | 8.22M | 1.35M | 453.85K | 842.50K |
| Income Tax | 26.41K | 10.27K | 6.01K | 17.55K | 20.55K |
| Shares Outstanding (Basic) | 17.34M | 13.23M | 13.23M | 7.77M | 3.38M |
| Shares Outstanding (Diluted) | 17.34M | 13.23M | 13.23M | 7.77M | 3.38M |
| EPS (Basic) | -0.89 | -0.62 | -1.84 | -0.15 | -0.29 |
| EPS (Diluted) | -0.89 | -0.62 | -1.84 | -0.15 | -0.29 |
| EBITDA | -16.14M | -8.22M | -1.35M | -451.53K | -841.20K |
| Depreciation & Amortization | 5.47K | 2.13K | 2.47K | 2.32K | 1.08K |